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Introduction
This is the third yearly article in the Tourette syndrome Research 
Highlights series, intended to share and comment on scientific and 
clinical advances on Gilles de la Tourette syndrome (TS) and other 
tic disorders. The highlights from 2017 article is being drafted on 
the Authorea online authoring platform, and readers are encour-
aged to add references or give feedback on our selections using 
the comment feature on that page. After the calendar year ends, the 
article is submitted as the annual update for the Tics collection on 
F1000Research.
Methods
A PubMed search was conducted using the search strategy “(“Tic 
Disorders” [MeSH] OR Tourette NOT Tourette[AU]) AND 
2016[PDAT] NOT 1950:2015[PDAT]”. On 06 Jan 2017, this search 
returned 186 citations, none of which had first appeared in 2017. 
The author also identified articles or news from other sources, such 
as colleagues, email lists, and professional meetings. The studies 
cited below were selected subjectively, but guided by a personal 
judgment of their potential importance to the field.
Results
Phenomenology and natural history
Epidemiology. A large, population-based health survey was 
explored to determine the rate of medically diagnosed TS in 
Canada1. One in 1,000 respondents had been diagnosed with TS, 
with the rate higher in youth (0.60%, vs. 0.09% in adults), and 
in males (risk ratio 5.31). Importantly, those diagnosed with TS 
had lower total education, income and employment. The results 
must be interpreted in light of the fact that many people with TS 
remain undiagnosed, or do not receive medical care.
Environmental effects on tic severity. Environmental effects 
on tics are typical in TS; they are included in the Diagnostic 
Confidence Index2 and have been demonstrated under careful 
laboratory conditions3,4. However, typical patient and clinician 
understanding of TS depends largely on self-report and parental 
symptom report. Two reports from 2016 highlight some surpris-
ing results from prospective observation. First, in one experi-
mental design, tics became less frequent during a short-term 
psychosocial stressor5. This finding is counterintuitive given the 
daily experience of patients and observations of clinicians, and 
supports further research in this area.
Barnea and colleagues recorded video from 41 children age 
6–18 with TS in each of five common, daily-life situations6. Their 
findings were illuminating. First, tic frequency correlated only 
moderately with reports of children or parents. Self-reported pre-
monitory urges were stronger when patients were more aware 
of their observed tics. Tic frequency was much higher when 
children were watching TV and much lower when alone, compared 
to doing homework, receiving attention when ticcing, or talking 
to a stranger. The results in the previous sentence differ from 
typical reports to clinicians, and suggest that developing methods 
for tic monitoring outside the office may be important to 
improve reliability and ecological validity in TS research.
Tic suppression. Previous studies have attempted to address 
TS as a generalized failure of action inhibition, but that concep-
tualization may cast the net too wide7–9. A 2013 publication from 
Wylie et al.10 had suggested some deficit in response inhibition 
(action stopping) in TS. In 2016, the group reported a new study 
in young adults with TS, now better controlled for comorbidity11. 
Although TS and control groups showed similar speed of cued 
movement and vocalization, the tic group was slower at stopping 
these responses.
Sensory phenomena. Many patients with TS describe sensory 
symptoms preceding or independent of their tics. One group 
recently took a new approach to studying sensation in TS based on 
a Theory of Event Coding12. Their results suggested that details or 
features of percepts are less integrated in TS; this finding applied to 
the group as a whole rather than relating to any obvious symptom or 
demographic characteristic. The authors speculate as to the possible 
underlying neurobiology.
Premonitory urges. Premonitory urges are usually reported 
later in life than tics are first observed. However, a large case 
series (N>1000) from one clinic suggests that premonitory urges 
“emerge much earlier than previously thought”: by age 8–10, 
>60% of children reported premonitory urges, and >75% could 
suppress tics13. Urges also “were found to be highly associated 
with ‘not just right experiences’.” The early onset of tic suppres-
sion is consistent with a report from the author’s laboratory on tic 
suppression in the first few months of tic disorder onset14.
Brandt et al.15 performed a careful experiment to investigate the 
timing of urges in relation to tics, compulsions and—as a com-
parison to a naturally arising urge—blinks when attempting to 
keep the eyes open. Another group examined tics and urge to tic at 
10- to 15-second intervals in 12 patients with moderate to severe 
TS; different patients had quite different relationships between 
urge and tic timing when examined at this temporal scale16. These 
observations show that careful phenomenological studies still 
have much to teach us about tic disorders.
Other. The frequency of anxiety and impulsivity in TS has 
suggested the possibility of a deficit in emotional self-regulation 
in some patients. A recent study examined specific emotional 
regulation approaches taken by adults with TS17. The TS and 
control groups did not differ on anxiety or depression symptom 
scores, but the TS group used suppression as a strategy more often 
than the control group.
Self-injurious behavior (SIB) is an important clinical problem 
in the minority of TS patients who experience it18. Sambrani 
et al.13 felt that their data supported lumping SIB with 
coprophenomena, and argue for it to “be conceptualized as 
a complex tic rather than a compulsion.” Others have found 
similar results19, though other results support a connection to 
compulsions20, one large study found SIB to fit better with 
ADHD symptoms21, and another linked it to both OCD and 
ADHD22.
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Self-reported depressive symptoms were as common and severe in 
TS as in tic-free patients with major depression, though people with 
TS endorsed irritability more frequently23.
Etiology
Genetics. An important, collaborative study showed that rare 
copy number variants (CNVs) increase the risk for TS24,25. This 
was true both generally for large CNVs, exceeding 1 million base 
pairs, and for CNVs previously linked to pathology. Specifically, 
NRXN1 and CNTN6 each conferred a substantially increased risk 
of TS: 20-fold and 10-fold, respectively. These associations give 
important impetus to research focusing on the cellular effects of 
these genes and perhaps related treatments. This research also 
confirms that the clear genetic risk for TS is spread across numer-
ous genes, because only 1% of patients with TS carry risk alleles in 
these two genes.
A population-based adult twin study of tics, ADHD and OCD 
found that the co-occurrence of tics and OCD can be partly 
explained by shared etiological influences26. The same is true to 
some extent for tics and ADHD. Another report concluded that 
social disinhibition in TS is heritable27. More research examining 
sub-dimensions of these phenotypes may clarify the situation.
Another potentially useful approach to TS genetic research was 
illustrated by 28, who sequenced candidate genes suggested by 
previous research in order to identify potential functional variants 
linked to TS.
Environmental risk factors and epidemiology. Identifying 
specific environmental risk factors for TS is important in its own 
right, and also because controlling for known environmental 
risks can improve the power of genetic studies. Previous studies 
have linked TS with lower birthweight, and more recently with 
maternal smoking during gestation29–31. Leivonen et al. reported 
the first nationwide pseudo-prospective (i.e., based on a Finnish 
national health registry) study of prenatal maternal smoking and 
TS32. In this sample, the hypothesized association of maternal 
smoking with TS per se was not significant, but maternal 
smoking during pregnancy was significantly associated with 
combined TS and ADHD, and the odds ratio for TS+ADHD 
following first trimester smoking was 4.0 (95% CI 1.2–13.5, 
p=.027). This association provides only modest support for the 
link between prenatal toxicity and TS. However, this study is 
consistent with the idea shared by many tic experts that the 
current nosology artificially separates tics from other common 
symptoms in people with TS.
Pathophysiology
Animal models. A face-valid animal model of tics has been a 
very important but elusive goal33. McCairn and colleagues have 
now published their important work characterizing a nonhuman 
primate tic model34. Temporary unilateral disinhibition of the 
nucleus accumbens (NA)—the ventral, more limbic-connected 
part of the striatum—produces vocalizations in monkeys that 
resemble vocal tics in human patients. The vocalizations some-
times were associated with local field potential (LFP) spikes in 
the NA, but not always; in the absence of local LFP spikes, phase 
coupling in the alpha frequency band between NA, anterior 
cingulate and primary motor cortex tended to be stronger. By 
contrast, disinhibition of the (more traditionally motor) dorso-
lateral putamen led to repetitive movements that the authors call 
“myoclonic tics,” whose phenomenology is less similar on its 
face to that of tics, and which were regularly preceded by LFP 
spikes.
Vasoactive intestinal peptide-expressing interneurons were 
targeted for developmental injury using a conditional expression 
model in mice35. These mice showed hyperactivity and altered fir-
ing of some cells at the onset of the transition from quiescence 
to locomotion. How this may relate to lower numbers of parval-
bumin-containing interneurons in TS36 is unclear. An interesting 
contrast based on the parvalbumin data is provided by a model 
in which fast-spiking interneurons in the dorsal striatum were 
ablated37. These mice developed anxiety and increased frequency 
of grooming rituals.
In another rodent model, D1CT-7 mice—in which dopamine 
D1 receptors are targeted— were compared to wild-type mice38. 
Spatial confinement triggered stress reflected by corticoster-
one release in both groups, but exacerbated abnormal behaviors 
in the D1CT-7 mice, such as digging, biting, jumping and motor 
perseveration. Stress also led to impaired prepulse inhibition, 
thought of as reflecting sensorimotor gating. Both the abnormal 
motor behavior and the prepulse inhibition deficit improved with 
clonidine, haloperidol, or SCH23390 (a dopamine D1 receptor 
antagonist). Collectively, these results support the potential utility 
of this model in screening new treatments for tic disorders.
Finally, spontaneously-occurring models of tics in other animals 
are of great interest39. Kalueff and colleagues provide a helpful 
review of the substantial body of knowledge available about 
stereotyped grooming patterns in rodents40, arguing appropriately 
that these patterns may be “useful for understanding the neural 
circuits that are involved in complex sequential patterns of action” 
in human disease, including in TS41.
Electrophysiology. In contrast to findings from previous studies 
in older patients, resting motor threshold and variability of motor 
evoked potential responses in 17 TS subjects, age 12–22, were 
increased versus controls, while the gain of motor excitability was 
reduced42. The authors suggest that these findings may relate to 
delayed maturation of the cortical-cortical and corticospinal motor 
networks in TS.
Local field potentials (LFP) in the posterolateral globus pallidus 
pars interna (GPi) were recorded at rest and during tics and nor-
mal voluntary movements in three adults with TS during deep 
brain stimulation surgery and compared to GPi LFP recordings 
in four Parkinson disease patients off medication43. Tics were 
associated with increased gamma (35–200 Hz) and high fre-
quency (200–400 Hz) activity, and with cross-frequency coupling 
(between the phase of beta band activity and the amplitude of the 
high-frequency oscillations).
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Negative reinforcement learning is a key variable in theories of 
behavior therapies proven effective for TS. In this context, the find-
ings of a 2016 report from Nottingham, England, are interesting. 
Behavioral and event-related potential data were collected during 
the learning of stimulus-response pairs using positive or negative 
reinforcement44. Participants included children age 9–17 with TS, 
ADHD, both or neither. Lower accuracy and smaller P3 amplitudes 
were observed in association with ADHD, but not TS.
O’Connor and colleagues have developed a cognitive-behavioral 
therapy approach to tic treatment, discussed below in the Treat-
ment section, based in part on electrophysiological findings. For 
instance, previous studies had identified a reduced P300 oddball 
effect in TS patients with or without OCD. This group has now 
reported a study of event-related potentials in adults with TS or a 
body-focused repetitive behavior disorder (such as trichotilloma-
nia) in comparison to a healthy control group45. The P300 oddball 
effect was lower in both patient groups before treatment, and 
increased with cognitive-psychophysiological treatment.
Neuroimaging studies. A structural brain MRI study in 103 
children with TS, age 7–17 years, and 103 matched control sub-
jects, found greater gray matter volume in TS in the posterior 
thalamus, hypothalamus and midbrain, and decreased white matter 
volume in orbital prefrontal and anterior cingulate cortex46. 
Structural abnormalities in these regions was hypothesized to 
influence somatosensory processing, decision making or rein-
forcement learning. Eddy and colleagues continued their research 
using theory of mind (ToM) approaches to TS, reporting on 
an fMRI study involving a task that required the subject to infer 
another person’s thoughts when making decisions47. TS subjects 
showed overall lower responses to the ToM task and to a control 
task, but also in several regions a lower increase with the ToM 
task compared to the control task. These regions included the 
posterior cingulate, right angular gyrus and right amygdala, 
regions involved in previous ToM studies in people without 
tics. Group differences correlated with various symptom severity 
measures, including a strong correlation of task-related tempo-
roparietal junction activation with premonitory urge severity.
SPECT imaging with a perfusion marker was used to investi-
gate the possible mechanism of action of deep brain stimulation 
in the internal GPi and in the medial thalamus48. Controls included 
sham stimulation in the TS group and unstimulated subjects 
without tics. Active stimulation in either site decreased regional 
blood flow in basal ganglia and cerebellum and increased perfusion 
to the frontal cortex, including the supplementary motor area.
Brain imaging studies include very large data sets, and have 
required development of novel statistical methods. Lessov- 
Schlaggar et al. argued thoughtfully that typical statistical 
analyses of a single variable at a time may be inadequate to 
find many important solutions to “complex disorders of brain 
development and function”, such as TS49.
Pharmacological studies. German researchers reported a fasci-
nating study in 37 medication-free adults with TS and 36 controls 
using magnetic resonance spectroscopy (MRS)50. The study tested 
the hypothesis that GABA, glutamine (Gln) and glutamate (Glu) 
concentrations in striatum and thalamus would differ in people 
with TS. Glutamine, Gln+Glu and the Gln:Glu ratio were lower 
in TS, more so in the striatum than in the thalamus. The striatal 
Gln concentration correlated negatively with tic severity on the day 
of the scan, and thalamic Glu concentration correlated negatively 
with premonitory urge severity. Surprisingly, these abnormalities 
tended to improve during treatment with aripiprazole. The authors 
work hard to minimize any effects of head motion, which might 
otherwise confound these results. The results overall suggest an 
abnormality in glutamatergic transmission in TS. Readers who are 
not MRS gurus may benefit from examining their Supplementary 
Figure 5, which demonstrates the challenges in eking out signal for 
these compounds.
Gremel et al.51 present data from an optogenetic study in mice, 
showing that removing cannabinoid type 1 (CB1) receptors from 
orbitofrontal cortex efferents to dorsal striatum prevents the mice 
from graduating from intentional to habitual lever pressing. The 
authors conclude that this cannabinoid-modulated orbitofrontal- 
striatal pathway is essential to the development of habits. 
As tics may be conceptualized as involving overenthusiastic 
habit formation circuitry, one might have expected the opposite 
result, given anecdotal beneficial short-term effects of cannabi-
noids on tic severity52.
In another mouse model, knocking out the histamine H3 
receptor impaired prepulse inhibition, and abolished or reduced 
dopaminergic signaling via both D1 and D2 receptors53. These 
results, combined with previous studies linking histamine to TS, 
support the development of histamine H3 receptor ligands for 
possible use in TS.
Clinical and neuropsychological studies. Thresholds for exter-
nally applied sensory stimuli were similar in adults with “pure” 
TS and controls54. These results, like those of a previous study55, 
demonstrate that the sensory symptoms of TS are central in 
origin, suggesting abnormalities in interoceptive awareness or 
central sensorimotor processing.
One interesting study focused on the clue that classic features of 
TS include echopraxia and suggestibility (the triggering of a tic by 
discussing or seeing it). Following up on their previous work56,57, 
Münchau and colleagues asked tic-free human control participants 
to imitate separately a tic and another, non-tic facial movement 
from a matched participant with TS58. While doing so, subjects 
watched video of one of the two movements. For non-tic move-
ments, TS subjects responded like controls, in that movements 
were performed more quickly when the video was congruent with 
the requested movement than when it was incongruent. However, 
when asked to execute a tic, TS subjects responded equally quickly 
regardless of the video content. The authors conclude that “tic-like 
movements do not occur as a consequence of a failure to inhibit 
motor output. Instead, tics might be considered highly overlearned 
behavior that can be triggered without interference by external, 
incompatible movement stimuli.”
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Most adults with TS feel that at least some of their tics are an 
eventual voluntary capitulation to an almost irresistible urge, 
though some tics are felt to be more truly involuntary. Research-
ers from Paris reported an interesting study of how adults with TS 
judge agency (the sense that one initiates and causes one’s own 
actions)59. The study involved manipulating in several different 
ways whether a participant’s hand movements were accurately 
reflected in the movements of a computer cursor. Those with TS 
recognized when their intended movements were substantially 
altered, yet were less aware that their intentions had been altered 
when the alterations comprised enhancement of their perform-
ance. These results add to a prior study of agency in adolescents 
with TS, in which awareness of their intention to move was 
earlier in those with greater tic suppression ability and later in 
those with more severe premonitory urges60. Together, these stud-
ies suggest that the sense of agency with intentional movement 
differs subtly in people with TS, and may relate to patients’ 
judgments of whether their tics are volitional.
Treatment
A meta-analysis of tic treatment discusses patient satisfaction in 
addition to efficacy and side effects, and concludes that there is 
good evidence supporting a favorable benefits:harms ratio for the 
most commonly used medications, but that “larger and better- 
conducted trials addressing important clinical uncertainties are 
[still] required”61.
Psychological interventions. Behavior therapy is now an accepted 
first-line treatment for tic disorders. Still, some practitioners 
retain misconceptions about its safety. A report on 228 partici-
pants in randomized controlled trials (RCTs) of Comprehensive 
Behavioral Intervention for Tics (CBIT) helps to confute those 
concerns62. Specifically, CBIT participants were no more likely 
to have new tics, have adverse events, increase tic medications or 
have an exacerbation in psychiatric symptoms relative to patients 
who received supportive therapy.
Factors that slow wider implementation of behavior therapies 
for tics include cost and a limited number of trained practition-
ers. Group (rather than individual) therapy is one option that 
could address these obstacles. A small study provided initial test-
ing of this possibility using a treatment and a control group. Both 
groups had improvements in quality of life, and the greatest 
improvements in motor tic severity occurred in the HRT group63. 
The most important conclusion from this pilot study was that the 
group format was acceptable and appears not to impair efficacy.
Another potential solution to the implementation concerns noted 
above is providing therapy online. Müller-Vahl and colleagues 
are beginning a large RCT that will test the efficacy of CBIT 
delivered by internet64. A commercial CBIT delivery system has 
been described, but (as of mid-2017) is not yet active.
Research continues on other psychotherapy approaches. Sup-
pressing tics is generally uncomfortable—leading to the theory 
of negative reinforcement that motivates CBIT and exposure 
and response prevention approaches to tic treatment—and in 
recent years Acceptance and Commitment Therapy for various 
conditions has become more popular, and pilot studies have 
appeared applying this approach to tics65,66. In this setting, Gev 
et al.67 report their study of 45 children and adolescents with TS 
who rated severity of tic urges, and were observed, during each of 
three 2-minute conditions: baseline (ticcing freely), tic suppression, 
and urge acceptance. Urges and discomfort decreased significantly 
during the acceptance condition, and more importantly, so did tic 
frequency. By contrast, tic urge intensity and self-rated discom-
fort increased during the tic suppression condition. These findings 
suggest that acceptance therapy may be better—accepted—by 
patients. It is now ripe for tests of long-term efficacy.
For some years, O’Connor, Leclerc and colleagues have devel-
oped and utilized a cognitive-behavioral-psychophysical treatment 
model for tic disorders. The treatment aims to address sensori-
motor function more broadly, including proprioception, response 
inhibition and perfectionism, rather than focusing on tics directly. 
In 2016, several important publications from their group addressed 
this approach, including an open study of 102 adults with a 
chronic tic disorder68, in which tic severity improved for both sim-
ple and complex tics, and the improvement remained at 6 months. 
Measures of self-esteem and perfectionism also improved. A pilot 
study in children age 8–16 was also reported69, followed by ini-
tial results with a manualized version of this therapy in children 
age 8–1270. This “cognitive-psychophysiological treatment” model 
provides another potential approach to treatment that may prove to 
have more generalizable benefits.
Medication. An open-label, rater-blind, 8-week study of deu-
tetrabenazine in TS provided positive results71. This compound is 
a deuterium-substituted tetrabenazine (a VMAT2 inhibitor) with 
slower elimination half-life, and was approved by the U.S. Food 
and Drug Administration (FDA) in 2017 as a treatment for chorea 
in Huntington disease, making it potentially available for off-label 
use for tics. Similarly, another VMAT 2 inhibitor, valbenazine, was 
approved in 2017 for treatment of tardive dyskinesia.
Adding to prior evidence of anti-tic efficacy, a prospective, open 
case series in 44 adults with TS found that aripiprazole helped 
non-tic symptoms as well as tics, though premonitory urges to 
tic were not significantly improved72. However, in May 2016, 
the FDA warned that aripiprazole can cause disinhibition in the 
form of impulse control disorders73. Similar side effects have been 
described for levodopa and dopamine agonists, but had not been 
recognized for aripiprazole, which is a partial agonist at dopamine 
receptors.
Other medication trials reported in 2016 include a failed add-on 
RCT with N-acetyl-cysteine74 and a case series suggesting iron 
supplementation may improve tics in TS patients with low serum 
ferritin75.
Neurosurgery. Surgery is an option for carefully selected patients 
with TS, yet several important questions remain76. The Galeazzi 
Institute in Milan, Italy, provided a progress report on their large 
sample of TS patients treated with deep brain stimulation (DBS), 
mostly in the ventromedial thalamus77. In 11 of 48 patients (23%), 
the device was removed after “inflammatory complications” or 
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poor compliance with follow-up. In the remaining 37 patients, 29 
had a more than 50% reduction in YGTSS scores (clinician-rated 
tic severity and impairment). In a separate publication, they argued 
that the patient’s symptoms beyond tics should be considered when 
a DBS target is selected78. Hartmann argued contrariwise that our 
current state of knowledge better supports a narrower focus on tic 
reduction in choosing a DBS target79.
The TS group from Maastricht, The Netherlands, reported posi-
tive unblinded follow-up results in five patients with refractory 
TS treated with DBS in the anterior GPi80, and a Chinese group 
reported unblinded 1-year follow-up of GPi DBS in 24 patients 
with TS, with improvement, on average, in both tics and OCD 
symptoms (50% reduction in mean YGTSS total tic score and 
27% reduction in mean Y-BOCS score; Supplementary File 1)81. 
Interestingly, this latter report includes one patient whose tics 
continued to improve after the DBS electrode was removed 
(p. 1025), consistent either with spontaneous improvement over 
time or with a micropallidotomy lesion effect.
DBS in a mouse model suggests that self-injurious behaviors, prob-
ably over-represented in TS patients referred for surgery, may be 
amenable to DBS of the subthalamic nucleus82.
Given the current lack of consensus on DBS methods in TS, 
gathering data on all DBS patient outcomes in TS is crucial, and 
a recent collaborative report described the establishment of the 
International Deep Brain Stimulation Registry and Database for 
Gilles de la Tourette syndrome83.
Other treatment. Many patients have reported to their doctor that 
music performance reduces their tic symptoms. Brown84 addressed 
this formally, surveying 183 musicians diagnosed with TS. On 
a scale of 1 (drastic symptom worsening) to 5 (drastic symptom 
improvement), subjects reported a mean of 4.45 for the effect of 
engaging in a musical activity (performance, not passive listening). 
This result strongly supports the patient anecdotes and suggests that 
formal music therapy could be tested in a randomized controlled 
trial for benefit on TS symptoms.
Some tic patients have been very interested in PANDAS, a name 
representing the hypothesis that obsessions, compulsions and tics 
represent an aberrant immune response to streptococcal infection 
in some children85. Recently a second double-blind study of intra-
venous immunoglobulin (IVIG) for OCD symptoms in PANDAS 
patients was published86. Unfortunately, although effects during 
the open label phase were substantial, there was little difference 
between the IVIG and control groups during the double-blind por-
tion of the study.
Tics, family and society
Three tic experts contributed a thoughtful review of the effect of 
tics and non-tic symptoms (or comorbidities, depending upon 
one’s nosological viewpoint) on social relationships and qual-
ity of life in TS87. Wadman and colleagues performed an in-depth 
study of 35 youth with TS, their parents, and school personnel 
to understand what problems TS caused at school88. Their 
conclusion will seem sadly familiar to TS patients and clini-
cians: “Young people and parents agreed more strongly with each 
other than they did with staff regarding school difficulties faced 
by individuals, and staff generally reported fewer TS-related 
difficulties.”
Additional reference sources
The first Frontiers Research Topic on TS was published this year, 
including over 30 articles on TS, many stemming from the 2015 
conference in London89. Thenganatt and Jankovic provided a 
useful review of TS90. A comprehensive review of Provisional Tic 
Disorder also appeared91; this diagnosis refers to children whose 
first tic was less than a year ago, similar to Transient Tic Disorder 
in earlier nosologies. A helpful overview of TS genetics92, and a 
review of epigenetic mechanisms and how they may prove to affect 
TS, both appeared in mid-201693.
Conclusions
Advances in many areas of TS research and clinical care were 
reported in 2016. Smaller pilot studies remain important for pur-
poses other than settling a question: they can be useful for testing 
feasibility, for improving methods, and for identifying new hypoth-
eses. (In fact, one of the most significant publications in TS history 
was a single-blind N-of-1 study94.) Several of the studies mentioned 
above are small studies that fulfill one or more of these goals.
Nevertheless, as the title of the 2016 Frontiers Research Topic 
suggests, TS research is beginning to grow from case series and 
small pilot studies into finding “new avenues through large-scale 
collaborative projects.” This change is important, especially in 
light of increasing recognition that reproducibility is an important 
concern in all of science, and clearly in neuroscience95,96. Larger 
samples are important to addressing this concern, and give greater 
hope for important new discoveries in the future.
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